AKY-1189

AKY-1189 · Aktis Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AKY-1189, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors [Phase 1]